Tissue Antigens. 2001 Feb;57(2):103-9.

A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes.

Schultz ES, Zhang Y, Knowles R, Tine J, Traversari C, Boon T, van der Bruggen P.

Source

Ludwig Institute for Cancer Research, Brussels, Belgium.

Abstract

Antigens encoded by MAGE genes are of particular interest for cancer immunotherapy because of their strict tumoral specificity and because they are shared by many tumors. Antigenic peptide EVDPIGHLY encoded by MAGE-3 and known to be presented by HLA-A*0101 is currently being used in therapeutic vaccination trials. We report here that a cytolytic T-lymphocyte (CTL) clone, which is restricted by HLA-B*3501, recognizes the same peptide and, importantly, lyses HLA-B*3501 tumor cells expressing MAGE-3. These results infer that the current clinical use of peptide EVDPIGHLY can now be extended to HLA-B*3501 patients.

PMID:: 11260504; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

HLA-B Gene - Genetics Home Reference

Supplemental Content

Save items

Related citations in PubMed

A MAGE-A1 peptide presented to cytolytic T lymphocytes by both HLA-B35 and HLA-A1 molecules. [Tissue Antigens. 2000]
A MAGE-A1 peptide presented to cytolytic T lymphocytes by both HLA-B35 and HLA-A1 molecules.
Luiten RM, Demotte N, Tine J, van der Bruggen P. Tissue Antigens. 2000 Jul; 56(1):77-81.
Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1. [J Immunol. 1999]
Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1.
Chaux P, Luiten R, Demotte N, Vantomme V, Stroobant V, Traversari C, Russo V, Schultz E, Cornelis GR, Boon T, et al. J Immunol. 1999 Sep 1; 163(5):2928-36.
A MAGE-3 peptide presented by HLA-B44 is also recognized by cytolytic T lymphocytes on HLA-B18. [Tissue Antigens. 2002]
A MAGE-3 peptide presented by HLA-B44 is also recognized by cytolytic T lymphocytes on HLA-B18.
Bilsborough J, Panichelli C, Duffour MT, Warnier G, Lurquin C, Schultz ES, Thielemans K, Corthals J, Boon T, van der Bruggen P. Tissue Antigens. 2002 Jul; 60(1):16-24.
Review Genes coding for tumor antigens recognized by human cytolytic T lymphocytes. [J Immunother Emphasis Tumor Im...]
Review Genes coding for tumor antigens recognized by human cytolytic T lymphocytes.
Coulie PG, Weynants P, Lehmann F, Herman J, Brichard V, Wölfel T, Van Pel A, De Plaen E, Brasseur F, Boon T. J Immunother Emphasis Tumor Immunol. 1993 Aug; 14(2):104-9.
Review Identification of genes coding for tumor antigens recognized by cytolytic T lymphocytes. [Methods. 1997]
Review Identification of genes coding for tumor antigens recognized by cytolytic T lymphocytes.
De Plaen E, Lurquin C, Lethé B, van der Bruggen P, Brichard V, Renauld JC, Coulie P, Van Pel A, Boon T. Methods. 1997 Jun; 12(2):125-42.

See reviews... See all...

Cited by 1 PubMed Central article

HLA-B8 association with late-stage melanoma--an immunological lesson? [BMC Med. 2006]
HLA-B8 association with late-stage melanoma--an immunological lesson?
Fensterle J, Trefzer U, Berger T, Andersen MH, Ugurel S, Becker JC. BMC Med. 2006 Mar 13; 4:5. Epub 2006 Mar 13.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes.
A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes.
Tissue Antigens. 2001 Feb ;57(2):103-9.

PubMed
Four half-siblings with infantile myofibromatosis: a case for autosomal-recessiv...
Four half-siblings with infantile myofibromatosis: a case for autosomal-recessive inheritance.
Clin Genet. 2001 Feb ;59(2):134-5.

PubMed
Essential role of the VirB machinery in the maturation of the Brucella abortus-c...
Essential role of the VirB machinery in the maturation of the Brucella abortus-containing vacuole.
Cell Microbiol. 2001 Mar ;3(3):159-68.

PubMed
The fleet feet of haematopoietic stem cells: rapid motility, interaction and pro...
The fleet feet of haematopoietic stem cells: rapid motility, interaction and proteopodia.
Br J Haematol. 2001 Mar ;112(3):644-54.

PubMed
Pharmacokinetics of sabeluzole and dextromethorphan oxidation capacity in patien...
Pharmacokinetics of sabeluzole and dextromethorphan oxidation capacity in patients with severe hepatic dysfunction and healthy volunteers.
Br J Clin Pharmacol. 2001 Feb ;51(2):164-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information